COVISHIELD VACCINE MAYBE RECOMMENDED FOR INTERNATIONAL USE

HIGHLIGHTS

• AstraZeneca is in talks with governments of many countries.
• AstraZeneca is also engaging with multilateral organizations and many other partners around the world.
• AstraZeneca wants broad and equitable access to the vaccine for ev...

SII RELEASES FAQ FACTSHEET FOR COVISHIELD VACCINE

HIGHLIGHTS

• SII has released FAQ Factsheet for Covishield Vaccine.
• The new factsheet details information for vaccine recipients regarding the benefits and common side-effects of the Covishield vaccine.
• The Covishield has been approved for re...

COVID-19 VACCINE: NOVAVAX TO DELIVER 100 MILLION DOSES TO THE U.S. BY JANUARY 2021

Highlights

• Novavax in the month of August had inked a deal with Serum Institute of India, the largest producer of vaccines in the world in order to produce a minimum of its COVID-19 vaccine candidate

• The U.S. drug developer had previously said that it will supply...

SERUM INSTITUTE CEO WARNS OF COVID-19 VACCINE SHORTAGE TILL 2024

HIGHLIGHTS

• Serum Institute CEO says that till 2024, coronavirus vaccine availability will not be enough.
• Two doses of vaccine are required to create immunity against coronavirus.

On Monday, 14 SEP 2020, Adar Poonawalla, the CEO of Se...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO BEGIN PHASE 2 TRIALS OF OXFORD VACCINE THIS WEEK

Highlights

• The Serum Institute of India has stated that it has shortlisted 10 centres across the nation to conduct Phase II and Phase III human clinical trials of COVID-19 vaccine developed by the University of Oxford

• On Monday, the national expert group on vacci...

INDIA’S COVID-19 TALLY AT 27,02,742, DEATH TOLL GOES UP TO 51,797

• Current Total Cases: 2,702,742

• Total Deaths : 51,797

• Cumulative recoveries : 1,977,779

• Active cases: 673,166

• Top five states that has the maximum number of cases : 

Maharashtra: Cases 604,358, number of deat...

NOVAVAX, SERUM INSTITUTE OF INDIA JOIN HANDS TO SUPPLY COVID-19 VACCINE

Highlights

• The Serum Institute of India will have exclusive rights for the COVID-19 vaccine in India and non-exclusive rights during the pandemic period in all countries except those designated as upper-middle or high-income nations

• The COVID-19 vaccine developed...

COVID-19 VACCINE: DCGI APPROVES PHASE 2 AND 3 CLINICAL TRIALS OF OXFORD VACCINE BY SERUM INSTITUTE

Highlights

• DCGI Dr V G Somani granted approval for conducting phase 2 and 3 human clinical trials by the SII

• ‘Covishield’ a potential vaccine for COVID-19 has been developed by the University of Oxford

• Before starting the phase 3 tria...

PUNE-BASED MYLAB GETS COMMERCIAL APPROVAL FROM ICMR FOR ANTIGEN KITS

Highlights

• The antigen kit developed by Mylab Discovery Solutions will cost Rs 450 per unit

• Serum Institute of India, CEO Adar Poonawalla has invested over Rs 100 crore and owns less than 50 percent stake in Mylab

• This antigen kit was co-develope...